€11.65
0.12% day before yesterday
L&S, Jun 28, 10:54 pm CET
ISIN
US29082K1051
Symbol
EMBC
Sector

Embecta Share price

$12.50
-0.59 4.51% 1M
-6.59 34.52% 6M
-6.43 33.97% YTD
-10.41 45.44% 1Y
-34.50 73.40% 3Y
-34.50 73.40% 5Y
-34.50 73.40% 10Y
NYSE, Closing price Fri, Jun 28 2024
ISIN
US29082K1051
Symbol
EMBC
Sector

Key figures

Market capitalization $720.88m
Enterprise Value $2.07b
PER (TTM) P/E ratio 10.27
EV/FCF (TTM) EV/FCF 220.22
EV/Sales (TTM) EV/Sales 1.83
P/S ratio (TTM) P/S ratio 0.64
P/B ratio (TTM) P/B ratio negative
Dividend yield 4.80%
Last dividend (FY23) $0.60
Sales growth (TTM) Sales growth 1.25%
Turnover (TTM) Turnover $1.13b
EBIT (operating result TTM) EBIT $228.40m
Free cash flow (TTM) Free cash flow $9.40m
Cash position $306.50m
EPS (TTM) EPS $1.22
P/E ratio expected 8.01
P/S ratio expected 0.65
EV/Sales expected 1.86
Short interest 8.08%
Show more

Is Embecta a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Embecta Share analysis

Unlock scores for free

Analyst opinions

4 Analysts have issued a Embecta forecast:

2x Hold
50%
2x Sell
50%

Analyst opinions

4 Analysts have issued a Embecta forecast:

Hold
50%
Sell
50%

Financial data from Embecta

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
1,133 1,133
1% 1%
100%
- Direct costs 391 391
9% 9%
35%
741 741
2% 2%
65%
- Selling and administrative expenses 391 391
11% 11%
35%
- Research and development costs 85 85
21% 21%
7%
265 265
21% 21%
23%
- Depreciation and amortization 37 37
16% 16%
3%
EBIT (operating result) EBIT 228 228
25% 25%
20%
Net profit 70 70
26% 26%
6%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Embecta share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Embecta Share News

Neutral
GlobeNewsWire
6 days ago
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association's 84th Scientific Sessions that point to the potential for adults with type 2 diabetes (T2D) to better manage insulin delivery through a patch pump with a larger, 300-...
Neutral
PRNewsWire
10 days ago
WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief Executive Officer and a member of the board of directors of Embecta Corp. (embecta), has been appointed to the Zimmer Biomet Board, effective immediately.
Positive
InvestorPlace
about one month ago
The White House recently confirmed increased tariffs on various Chinese goods. Investors and traders are on the lookout for stocks to benefit from China tariffs as the change could significantly impact many industries, including the U.S. automotive industry, electric vehicles (EVs) and others.
More Embecta News

Company profile

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Head office United States
CEO Devdatt Kurdikar
Employees 2,200
Founded 1924
Website www.embecta.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now